Recent advances revolutionize treatment of metastatic prostate cancer

By Madan Ravi A   Arlen Philip M  

Future Oncology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1133-1144

Future Medicine

Access to resources Recommend Favorite

Is there an optimal treatment sequencing strategy for metastatic castration-resistant prostate cancer?

By Aragon-Ching Jeanny B  

Future Oncology, Vol. 9, Iss. 5, 2013-05 ,pp. : 619-622

Future Medicine

Access to resources Recommend Favorite

Current Status of Thalidomide and CC-5013 in the Treatment of Metastatic Prostate Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1058-1069

Bentham Science Publishers

Access to resources Recommend Favorite

PSA Response to Secondary Androgen Deprivation Following Failed Treatment of Metastatic Prostate Cancer with the Antiandrogen Casodex

By Fabozzi S.J.   Kolm P.   Schellhammer P.F.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 2, 1995-03 ,pp. : 64-66

Elsevier

Access to resources Recommend Favorite

TROPIC: Phase III trial of cabazitaxel for the treatment of metastatic castration-resistant prostate cancer

By Oudard Stephane  

Future Oncology, Vol. 7, Iss. 4, 2011-04 ,pp. : 497-506

Future Medicine

Access to resources Recommend Favorite